Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine. - Gadelha MR; Casagrande A; Strasburger CJ; Bidlingmaier M; Snyder PJ; Guitelman MA; Boguszewski CL; Buchfelder M; Shimon I; Raverot G; Tóth M; Mezősi E; et al. (The Journal of clinical endocrinology and metabolism, 2024)